David Krempa | executive |
Sean Brynjelsen | executive |
James Gruber | executive |
Good afternoon, and welcome to Eton Pharmaceuticals Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. At this time, I'd like to turn it over to David Krempa, Chief Business Officer at Eton Pharmaceuticals. Please proceed.